lysosomal 功能障碍的不同模式在初级渐进性失言症的临床病理形式中被观察到
Imogen J Swift1,2, Simon Sjödin3, Johan Gobom3,4
1UK Dementia Research Institute at University College London, UCL Queen Square Institute of Neurology, University College London, London, UK.
Journal of neurology
|November 2, 2023
概括
溶解体功能障碍与前性痴呆症 (FTD) 有关. 这项研究发现脑脊液中明显的蛋白质变化,用于非流动和语义变体的初级渐进性失言症 (PPA),但不是logopenic变体.
科学领域:
- 神经科学是一个神经科学.
- 生物化学 生物化学
- 遗传学 是一个遗传学.
背景情况:
- 内溶性体功能障碍越来越多地与前性痴呆症 (FTD) 相关.
- 初级渐进性失言症 (PPA) 是FTD的一个语言变体,具有不同的亚型.
- 了解PPA亚型的分子变化对于诊断和治疗至关重要.
研究的目的:
- 为了研究PPA变异的脑脊液 (CSF) 中的差异性溶解体蛋白质改变.
- 为了比较非流动变体PPA (nfvPPA),语义变体PPA (svPPA),逻辑变体PPA (lvPPA) 和健康对照之间的蛋白质概况.
主要方法:
- 在36名PPA患者和19名对照患者的CSF中使用质谱测量量了18种蛋白质.
- 在nfvPPA,svPPA,lvPPA和对照组中分析了蛋白质度.
主要成果:
- 在nfvPPA中,甲素 (B,D,F,L1,Z) 的度降低,AP-2复合体子单元β,化物GM2激活剂,β-hexosaminidase子单元β,组织alpha L-fucosidase和ubiquitin的度降低.
- 在svPPA中减少了粉样βA4蛋白,甲素Z和二乙酶2的度.
- 在lvPPA中没有发现任何显著的蛋白质异常.
结论:
- 溶解体蛋白质的改变在PPA变体中是不同的.
- nfvPPA和svPPA表现出明显的溶酶体蛋白质变化的模式.
- 这些发现表明,在非阿尔茨海默氏症病理的PPA亚型中, lysosomal功能受损可能更为普遍.
相关概念视频
01:22Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
01:15Parkinson's Disease: Overview
564
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
564
01:26Alzheimer's Disease: Overview
498
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
498
03:03Amyloid Fibrils
9.6K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.6K